Table 5. Annual cost estimation for prevention, management and treatment of cervical lesions, cancer and genital warts expressed in $ 2015.
| Parameter | Prevalence 2015 | Cost per item | Base case cost | Range | |
|---|---|---|---|---|---|
| Number | $ 2015 | $ 2015 | Lower (-50%) | Higher (+50) | |
| Screening | |||||
| Pap smear | 8 229 | 22 | 180 301 | 90 150 | 270 451 |
| Total VIA screened | 11 248 | 53 | 601 050 | 300 525 | 901 576 |
| Biopsy | 532 | 158 | 83 859 | 41 929 | 125 788 |
| 20 009 | 865 210 | 432 605 | 1 297 815 | ||
| Diagnosed cervical lesions | |||||
| Treatment with LEEP | 309 | 2 049 | 633 195 | 316 598 | 949 793 |
| VIA positive treated with cryotherapy | 1 408 | 96 | 169 647 | 84 823 | 254 470 |
| Follow up of LSIL with Pap smear 6 months later and antibiotics (3 drugs) | 12 862 | 52 | 664 995 | 332 497 | 997 492 |
| Treatment of HSIL with hysterectomy during anesthesia | 1 917 | 3 941 | 7 554 366 | 3 777 183 | 11 331 549 |
| 16 496 | 9 022 203 | 4 511 102 | 13 533 305 | ||
| Diagnosed with cervical cancer | |||||
| FIGO I-Ib1 | 22 | 6 405 | 140 899 | 70 450 | 211 349 |
| FIGO Ib2-II | 22 | 25 527 | 561 601 | 280 800 | 842 401 |
| FIGO III | 110 | 24 992 | 2 749 172 | 1 374 586 | 4 123 759 |
| FIGO IV | 66 | 23 923 | 1 578 905 | 789 453 | 2 368 358 |
| 220 | 5 030 578 | 2 515 289 | 7 545 867 | ||
| Genital warts | |||||
| Wart removal with cauterization | 116 | 552 | 63 997 | 31 999 | 95 996 |
| Wart removal with Podophyllotoxin and antibiotics | 5 995 | 161 | 966 720 | 483 360 | 1 450 080 |
| 6 111 | 1 030 717 | 515 359 | 1 546 076 | ||
| Total | 42 836 | 15 948 708 | 7 974 354 | 23 923 062 | |